PharmExec Picks:
Having trouble viewing this e-mail? Click here.
feed back

Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE


Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what's trending on social media.

Top 5 Stories :
HBA Woman of the Year: J&J’s Denice Torres
The Indiana native must have struck an image: sandy-brown hair, athletic build, light hazel eyes, and a demeanor bristling with ambition.
Read more
Biosimilars Ramp-Up: Five Themes for the Future
In-boxes and newswires filled up on March 6 with victory cheers, notes of caution, and, of course, ubiquitous calls for regulatory clarity.
Read more
UnitedHealth’s Acquisition of PBM Catamaran Heralds Escalating Price War With Drugmakers
This month’s announcement by UnitedHealth Group of its planned acquisition of pharmacy benefits manager (PBM) Catamaran for $12.8 billion officially puts the pharmaceutical industry on notice that the “war” on drug prices is escalating.
Read more
What’s Real in Rare Disease
Rare diseases are life-threatening conditions affecting fewer than 200,000 patients. This may seem definably small, but in the aggregate, rare diseases are hardly rare: some 350 million people worldwide have a rare disease, more than the total for cancer and AIDS combined.
Read more
Evaluating the Impact of the Falsified Medicines Directive in Switzerland
In early 2015, the British Embassy in Switzerland and United Kingdom Trade & Investment organized a workshop in Berne, Switzerland to bring together expert stakeholders, medicines authentication experts, and other leading professionals to provide a forum to communicate the impact of the FMD in Switzerland.
Read more
Sponsored
Four Perspectives That Help Build Business Advantage
How to join the elite group of life sciences companies achieving sustained growth Read more.
Trending on Social Media :
FDA Steps Up Foreign Inspections
New legislation and changes in policy at FDA are leading to better control of the API supply chain.
Read more
In a Dynamic Healthcare Market, Only the Adaptive Survive
“It is not the strongest of the species that survives... It is the one that is most responsive to change.” In today’s dynamic healthcare market, these words attributed to Darwin have never been more relevant, writes Brad Ansley.
Read more
Sunshine Over Europe: Event Sheds Light on Disclosure
 Sunshine was a strong feature of this week's CBI’s Global Transparency Reporting Congress in London, both in terms of the unseasonably hot weather outside and in the frequent referencing of the US experience of healthcare spend disclosure.
Read more
Follow Us